Healthcare -
Biotechnology - NASDAQ - US
$ 422.0
1.21 %
$ 109 B
Market Cap
-219.79
P/E
Price Target
Average
18.14%
Revenue Forecast
Estimate
15.88%
EBIT
Estimate
15.44%
Net Income
Estimate
22.73%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Vertex Pharmaceuticals Incorporated
Wall Street analysts predict an average 1-year price target for VRTX of $499 , with forecasts ranging from
a
low of
$361 to a high of $600 .
VRTX Lowest Price Target
Wall Street Target
361 USD
-14.45%
VRTX Average Price Target
Wall Street Target
499 USD
18.14%
VRTX Highest Price Target
Wall Street Target
600 USD
42.18%
REVENUE FORECAST
Revenue Forecast Chart VRTX
EBIT FORECAST
EBIT Forecast Chart VRTX
NET INCOME FORECAST
Net Income Chart VRTX